Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease

Blood Coagulation and Fibrinolysis

Volumn 26, Issue 3, 2015, Pages 290-297

  Faraoni, David ^a,b   Rozen, Laurence ^a   Willems, Ariane ^a   Torres, Cristel Sanchez ^a   Pereira, Luis M ^b   Demulder, Anne ^a   Van Der Linden, Philippe ^a  

^a HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

hyperfibrinolysis; pediatric cardiac surgery; rotational thromboelastometry; tranexamic acid

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ANESTHESIA INDUCTION; ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; EXTRINSIC ACTIVATION WITH TISSUE FACTOR TEST; HEMATOLOGICAL PROCEDURE; HUMAN; HYPERFIBRINOLYSIS; IN VITRO STUDY; PRIORITY JOURNAL; ROTATIONAL THROMBOELASTOMETRY; SENSITIVITY AND SPECIFICITY; BLOOD; DRUG EFFECTS; FIBRINOLYSIS; HEART DEFECTS, CONGENITAL; HEMORRHAGIC DISORDERS; INFANT; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PRESCHOOL CHILD; PROCEDURES; PROSPECTIVE STUDY; THROMBOELASTOGRAPHY;

ANTIFIBRINOLYTIC AGENTS; CHILD; CHILD, PRESCHOOL; FIBRINOLYSIS; HEART DEFECTS, CONGENITAL; HEMORRHAGIC DISORDERS; HUMANS; IN VITRO TECHNIQUES; INFANT; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THROMBELASTOGRAPHY; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID;

EID: 84926466432     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000238     Document Type: Article

References (24)

1. Miller BE, Mochizuki T, Levy JH, Bailey JM, Tosone SR, Tam VK, Kanter KR. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997; 85:1196-1202
2. Arnold P. Treatment and monitoring of coagulation abnormalities in children undergoing heart surgery. Paediatr Anaesth 2011; 21:494-503
3. Van Aelbrouck C, Englberger L, Faraoni D. Review of the fibrinolytic system: comparison of different antifibrinolytics used during cardiopulmonary bypass. Recent Pat Cardiovasc Drug Discov 2012; 7:175-179
4. Ngaage DL, Bland JM. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent?. Meta-analysis of randomised and large matched observational studies. Eur J Cardiothorac Surg 2010; 37:1375-1383
5. Eaton MP. Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg 2008; 106:1087-1100
6. Faraoni D, Goobie SM. New insights about the use of tranexamic acid in children undergoing cardiac surgery: from pharmacokinetics to pharmacodynamics. Anesth Analg 2013; 117:760-762
7. Faraoni D. Safety of tranexamic acid in pediatric cardiac surgery: what we do not know. Eur J Cardiothorac Surg 2011; 40:1550-1551
8. Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11:307-314
9. Nielsen VG, Cohen BM, Cohen E. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. Blood Coagul Fibrinolysis 2006; 17:75-81
10. Kupesiz A, Rajpurkar M, Warrier I, Hollow W, Tosun O, Lusher J, Chitlur M. Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography. Blood Coagul Fibrinolysis 2010; 21:320-324
11. Yee BE, Wissler RN, Zanghi CN, Feng C, Eaton MP. The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro. Anesth Analg 2013; 117:767-772
12. Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, et al. Comparative analysis of antifibrinolytic medications in pediatric heart surgery. J Thorac Cardiovasc Surg 2012; 143:550-557
13. Faraoni D, Willems A, Melot C, De Hert S, Van der Linden P. Efficacy of tranexamic acid in paediatric cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2012; 42:781-786
14. Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology 2013; 118:853-862
15. Andersson L, Nilsoon IM, ColleenS, Granstrand B, Melander B. Role of urokinase and tissue activator in sustaining bleeding and themanagement thereofwith eaca and amca. Ann N Y Acad Sci 1968; 146:642-658
16. Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002; 97:390-399
17. Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifer B, et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011; 113:1003-1012
18. Iqbal A, Morton C, Kong KL. Fibrinolysis during anaphylaxis, and its spontaneous resolution, as demonstrated by thromboelastography. Br J Anaesth 2010; 105:168-171
19. Hunt BJ, Raza I, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients: a reply to a rebuttal. J Thromb Haemost 2013; 11:1437-1438
20. Dekker SE, Viersen VA, Duvekot A, de Jong M, van den Brom CE, van de Ven PM, et al. Lysis onset time as diagnostic rotational thromboelastometry parameter for fast detection of hyperfibrinolysis. Anesthesiology 2014; 121:89-97
21. Dirkmann D, Gorlinger K, Peters J. Assessment of early thromboelastometric variables from extrinsically activated assays with and without aprotinin for rapid detection of fibrinolysis. Anesth Analg 2014. doi: 10.1213/ANE.0000000000000333
22. Faraoni D, Savan V, Levy JH, Theusinger OM. Goal-directed coagulation management in the perioperative period of cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27:1347-1354
23. Mojcik C. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 2001; 71:745-754
24. Eisses M. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children. J Cardiothorac Vasc Anesth 2008; 22:53-59